CNM Publications 2009 to Present

Selected Publications

Found 116 results
Author Title Type [ Year(Asc)]
Ersoy SC, Heithoff DM, Barnes L, Tripp GK, House JK, Marth JD, Smith JW, Mahan MJ.  2017.  Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing.. EBioMedicine. 20:173-181.
Ikemoto H, Lingasamy P, Willmore A-MAnton, Hunt H, Kurm K, Tammik O, Scodeller P, Simón-Gracia L, Kotamraju VRamana, Lowy AM et al..  2017.  Hyaluronan-binding peptide for targeting peritoneal carcinomatosis.. Tumour Biol. 39(5):1010428317701628.
Mann AP, Scodeller P, Hussain S, Braun GB, Mölder T, Toome K, Ambasudhan R, Teesalu T, Lipton SA, Ruoslahti E.  2017.  Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's disease.. Nat Commun. 8(1):1403.
Scodeller P, Simón-Gracia L, Kopanchuk S, Tobi A, Kilk K, Säälik P, Kurm K, Squadrito MLeonardo, Kotamraju VRamana, Rinken A et al..  2017.  Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide.. Sci Rep. 7(1):14655.
Toome K, Willmore A-MA, Paiste P, Tobi A, Sugahara KN, Kirsimäe K, Ruoslahti E, Braun GB, Teesalu T.  2017.  Ratiometric in vivo auditioning of targeted silver nanoparticles.. Nanoscale. 9(28):10094-10100.
Yang WHo, Heithoff DM, Aziz PV, Sperandio M, Nizet V, Mahan MJ, Marth JD.  2017.  Recurrent infection progressively disables host protection against intestinal inflammation. Science. 358(6370)
Hunt H, Simón-Gracia L, Tobi A, Kotamraju VRamana, Sharma S, Nigul M, Sugahara KN, Ruoslahti E, Teesalu T.  2017.  Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles.. J Control Release. 260:142-153.
Sharma S, Kotamraju VRamana, Mölder T, Tobi A, Teesalu T, Ruoslahti E.  2017.  Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth.. Nano Lett. 17(3):1356-1364.
Sharma S, Mann AP, Mölder T, Kotamraju VRamana, Mattrey R, Teesalu T, Ruoslahti E.  2017.  Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment.. J Control Release. 268:49-56.